Press release
Global Artificial Intelligence In Clinical Trials Market to grow at a CAGR of 12.04% by 2032, Evaluates DelveInsight
According to DelveInsight's analysis, The demand for AI in clinical trials is experiencing strong growth, primarily fueled by the rising global prevalence of chronic diseases, including diabetes, cardiovascular disorders, respiratory conditions, and cancer. This growth is further bolstered by increasing investments and funding dedicated to enhancing drug discovery and development processes. Additionally, the expanding trend of strategic partnerships and collaborations among pharmaceutical, biotechnology, and medical device companies is accelerating the adoption of AI-driven clinical trial solutions. Together, these factors are anticipated to drive significant expansion in the AI in clinical trials market from 2025 to 2032.DelveInsight's "Artificial Intelligence In Clinical Trials Market Insights, Competitive Landscape and Market Forecast-2032" report provides the current and forecast market outlook, forthcoming device innovation, challenges, market drivers and barriers. The report also covers the major emerging products and key Artificial Intelligence In Clinical Trials companies actively working in the market.
To know more about why North America is leading the market growth in the Artificial Intelligence In Clinical Trials market, get a snapshot of the report Artificial Intelligence In Clinical Trials Market Trends
https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Artificial Intelligence In Clinical Trials Overview
Artificial Intelligence (AI) in Clinical Trials refers to the use of AI technologies such as machine learning, natural language processing, and predictive analytics-to optimize and accelerate the clinical research process. AI can enhance patient recruitment, identify suitable trial participants, predict treatment responses, monitor real-time data, and streamline protocol design. By reducing costs, improving efficiency, and increasing the accuracy of trial outcomes, AI is transforming how new drugs and therapies are developed and evaluated in clinical settings.
DelveInsight Analysis: The clinical trials market utilizing Artificial Intelligence was estimated at USD 1,350.79 million in 2024 and is projected to grow at a CAGR of 12.04% from 2025 to 2032, reaching approximately USD 3,334.47 million by 2032.
Artificial Intelligence In Clinical Trials Market Insights
Geographically, North America is expected to hold the largest share of the AI in the clinical trials market. This leadership is driven by several factors, including the rising prevalence of chronic diseases, substantial investments in research and development, and a growing number of clinical trials conducted in the region. Furthermore, increasing research collaborations and partnerships between pharmaceutical and medical device companies, along with the development of advanced AI solutions, are accelerating market growth. These elements are boosting the demand for AI-driven clinical trial solutions to efficiently manage trial complexities, supporting the expansion of the market in North America from 2025 to 2032.
To read more about the latest highlights related to Artificial Intelligence In Clinical Trials, get a snapshot of the key highlights entailed in the Artificial Intelligence In Clinical Trials
https://www.delveinsight.com/report-store/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Recent Developments in the Artificial Intelligence In Clinical Trials Market Report
• In May 2025, Avant Technologies, Inc. (OTCQB: AVAI) and their joint venture partner, Ainnova Tech, Inc., announced the initiation of acquisition discussions aimed at bolstering their presence in the rapidly evolving AI-driven healthcare sector.
• In March 2025, Suvoda launched Sofia, an AI-powered assistant designed to streamline clinical trial management. Built to support study teams, Sofia simplifies access to and review of critical trial information by delivering intelligent, real-time insights. This innovation enhances operational efficiency, reduces manual workload, and empowers teams to make faster, data-driven decisions throughout the trial lifecycle.
• In December 2024, ConcertAI and NeoGenomics announced the launch of CTO-H, a next-generation AI software solution for research analytics, clinical trial design, and operational optimization. CTO-H delivers an unparalleled research data platform, offering unmatched scale, longitudinal patient insights, and deep biomarker data, enabling more precise, efficient, and data-driven clinical development strategies.
• In June 2024, Lokavant introduced SpectrumTM, the first AI-powered clinical trial feasibility platform created to enhance trial performance throughout the clinical development lifecycle. Spectrum enables study teams to anticipate, manage, and optimize trial timelines and expenses in real time.
• Thus, owing to such developments in the market, rapid growth will be observed in the Artificial Intelligence In Clinical Trials market during the forecast period
Key Players in the Artificial Intelligence In Clinical Trials Market
Some of the key market players operating in the Artificial Intelligence In Clinical Trials market include- TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, and others
Which MedTech key players in the Artificial Intelligence In Clinical Trials market are set to emerge as the trendsetter explore @ Key Artificial Intelligence In Clinical Trials Companies
https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Analysis on the Artificial Intelligence In Clinical Trials Market Landscape
To meet the growing demands of clinical trials, leading companies in the AI in Clinical Trials market are developing advanced AI solutions aimed at optimizing trial efficiency, improving patient recruitment, and enhancing clinical trial design at investigator sites. For example, in January 2025, Risklick introduced Protocol AI, the first AI-driven software specifically tailored for clinical trials in the medical device sector. Protocol AI streamlines trial development, significantly reducing time, costs, and risks while accelerating patient access to innovative treatments. This breakthrough underscores a major step forward in bringing medical devices to market more efficiently and cost-effectively.
Consequently, the software segment is expected to experience strong growth during the forecast period, fueling the overall expansion of the AI in the clinical trials market.
Scope of the Artificial Intelligence In Clinical Trials Market Report
• Coverage: Global
• Study Period: 2022-2032
• Artificial Intelligence In Clinical Trials Market Segmentation By Product Type: Self-Injectors, Needle-Free, Auto-Injectors, Wearable Injectors, and Insulin Pens
• Artificial Intelligence In Clinical Trials Market Segmentation By Drug Loading: Prefilled Injection Devices and Fillable Injection Devices
• Artificial Intelligence In Clinical Trials Market Segmentation By Reusability: Reusable and Disposable
• Artificial Intelligence In Clinical Trials Market Segmentation By Site of Delivery: Intramuscular, Subcutaneous, and Intra Dermal
• Artificial Intelligence In Clinical Trials Market Segmentation By Application: Artificial Intelligence In Clinical Trials Market Segmentation By End User: Hospital & Retail Pharmacy, E-Commerce, and others
• Artificial Intelligence In Clinical Trials Market Segmentation By End User: Hospitals, Specialty Clinics, and Homecare Settings
• Artificial Intelligence In Clinical Trials Market Segmentation By Geography: North America, Europe, Asia-Pacific, and Rest of the World
• Key Artificial Intelligence In Clinical Trials Companies: TEMPUS, NetraMark, ConcertAI, AiCure, Medpace, Inc., ICON plc, Charles River Laboratories, Dassault Systèmes, Oracle, Certara, Cytel Inc., Phesi, DeepHealth, Unlearn.ai, Inc., H1, TrialX, Suvoda LLC, Risklick, Lokavant, Research Solutions, and others
• Porter's Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Interested in knowing how the Artificial Intelligence In Clinical Trials market will grow by 2032? Click to get a snapshot of the Artificial Intelligence In Clinical Trials Market Analysis
https://www.delveinsight.com/sample-request/ai-in-clinical-trials-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Contact Us
Gaurav Bora
info@delveinsight.com
+14699457679
www.delveinsight.com
About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.
Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Artificial Intelligence In Clinical Trials Market to grow at a CAGR of 12.04% by 2032, Evaluates DelveInsight here
News-ID: 4216059 • Views: …
More Releases from DelveInsight Business Research

Global Uterine Fibroids Treatment Devices Market to grow at a CAGR of 8.57% by 2 …
According to DelveInsight's analysis, The growth in demand for Uterine Fibroids Treatment Devices is largely driven by the rising prevalence The demand for uterine fibroids treatment devices is rising due to the growing prevalence of uterine fibroids, especially among women of reproductive age, creating a strong need for effective therapies. Increased awareness of the condition and improved healthcare access are facilitating earlier diagnoses, enabling timely interventions. Technological innovations have led…

Global Artificial Intelligence In Diagnostics Market to grow at a CAGR of 11.16% …
According to DelveInsight's analysis, The increasing prevalence of cancer is driving the need for advanced diagnostic solutions, making Artificial Intelligence (AI) an essential tool for early detection and precision oncology. By integrating AI with medical imaging techniques like CT scans, MRIs, mammograms, and pathology slides, diagnostic accuracy is significantly enhanced, human errors are reduced, and cancer detection is accelerated, ultimately leading to improved patient outcomes.
DelveInsight's "Artificial Intelligence In Diagnostics Market…

Human Papillomavirus Associated Cancer Pipeline 2025: Therapies, MOA Insights, a …
Las Vega (Nevada), United States //- As per DelveInsight's assessment, globally, Human Papillomavirus Associated Cancer pipeline constitutes key companies continuously working towards developing Human Papillomavirus Associated Cancer treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Human Papillomavirus Associated Cancer Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Human…

Insulin Resistance Pipeline 2025: MOA, ROA, FDA-Approved Drugs, and Clinical Tri …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Insulin Resistance pipeline constitutes 8+ key companies continuously working towards developing 10+ Insulin Resistance treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
"Insulin Resistance Pipeline Insight, 2025" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Insulin Resistance Market.
The Insulin…
More Releases for Artificial
Artificial Intelligence or Artificial Soul by Denise White
Author Denise White exposes the subtle societal forces shaping young minds and offers profound wisdom to help children develop resilience against artificial influences.
As artificial intelligence continues to permeate every aspect of modern life, from self-driving cars to virtual assistants, a critical question arises: Are we sacrificing our authenticity and human essence for the sake of technological advancement? In her latest book, Guarding the Child's Imagination , author Denise White sheds…
Artificial Neural Network Software Market: Advancements in Artificial Neural Net …
The Report on "Artificial Neural Network Software Market" provides Key Benefits, Market Overview, Regional Analysis, Market Segmentation, Future Trends Upto 2030 by Infinitybusinessinsights.com. The report will assist reader with better understanding and decision making.
Market Growth of Artificial Neural Network Software Market: The artificial neural network software market is experiencing robust growth as organizations across various industries increasingly leverage AI-driven solutions to enhance decision-making, automate processes, and gain actionable insights from…
Global Artificial Intelligence Market, Global Artificial Intelligence Industry, …
Major players in the artificial intelligence market are Google, IBM, Baidu, Microsoft, Apple Inc., Ipsoft, NVIDIA Corporation, Samsung Electronics Co.Ltd, and Micro Strategy Inc.
The Global Artificial Intelligence Market is expected to grow from USD 28.42 billion in 2019 to USD 40.74 billion in 2020 at a compound annual growth rate (CAGR) of 43.39%. The growth is mainly due to the COVID-19 health emergency across the globe that has led to…
Artificial Iris Market - Industry Analysis, Size, Share, Growth, Trends, and For …
The global Artificial Iris Market is anticipated to gain the market worth of US$ 16.28 million by 2025, expanding at a CAGR of 6.39% during the forecast period 2019-2025. The natural pupil controls the amount of light that enters the eye and people with pupil or iris abnormalities may experience glare or haloes in sunlight or bright artificial light. Patients may also feel self-conscious about the appearance of their eyes…
Global Artificial Organs Market Facts, Figures and Analytical Insights, 2018 to …
Artificial Organs Market Introduction
Artificial organ is an engineered device or tissue that is implanted into the human body. These artificial organs replace a natural organ in order to duplicate a specific function so that the patient can return to a normal life. It is a medical device with biochemical or mechanical function such as lung, heart, liver, kidney, or neurosensory organs.
Artificial organs are surgically implanted or are extra…
Artificial Kidney Market Report 2018: Segmentation by Type (Wearable Artificial …
Global Artificial Kidney market research report provides company profile for Medtronic, DaVita, Merit Medical Systems, NIPRO Medical Corporation, Nikkiso, B. Braun Melsungen AG, Kawasumi Laboratories, Fresenius, Baxter, Asahi Kasei Medical, Xcorporeal and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for…